Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer

Tumor angiogenesis is essential during lung cancer development and targeting angiogenesis may possess a potential therapeutic value. The present study demonstrates that azithromycin, a Food and Drug Administration-approved antibiotic drug, is a novel tumor angiogenesis inhibitor. Azithromycin inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fajiu, Huang, Jie, Ji, Dongyuan, Meng, Qinghua, Wang, Chuanhai, Chen, Shi, Wang, Xiaojiang, Zhu, Zhiyang, Jiang, Cheng, Shi, Yi, Liu, Shuang, Li, Chenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494938/
https://www.ncbi.nlm.nih.gov/pubmed/28693139
http://dx.doi.org/10.3892/ol.2017.6103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494938/
https://www.ncbi.nlm.nih.gov/pubmed/28693139
http://dx.doi.org/10.3892/ol.2017.6103

Ejemplares similares